"Chagas Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.
| Descriptor ID |
D014355
|
| MeSH Number(s) |
C03.752.300.900.200
|
| Concept/Terms |
Chagas Disease- Chagas Disease
- Chagas' Disease
- American Trypanosomiasis
- Trypanosomiasis, American
- Trypanosomiasis, South American
- South American Trypanosomiasis
- Trypanosoma cruzi Infection
- Infection, Trypanosoma cruzi
- Infections, Trypanosoma cruzi
- Trypanosoma cruzi Infections
|
Below are MeSH descriptors whose meaning is more general than "Chagas Disease".
Below are MeSH descriptors whose meaning is more specific than "Chagas Disease".
This graph shows the total number of publications written about "Chagas Disease" by people in this website by year, and whether "Chagas Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 3 | 1 | 4 |
| 2012 | 4 | 1 | 5 |
| 2013 | 8 | 1 | 9 |
| 2014 | 12 | 1 | 13 |
| 2015 | 8 | 4 | 12 |
| 2016 | 7 | 2 | 9 |
| 2017 | 6 | 3 | 9 |
| 2018 | 11 | 0 | 11 |
| 2019 | 8 | 0 | 8 |
| 2020 | 11 | 1 | 12 |
| 2021 | 8 | 2 | 10 |
| 2022 | 11 | 0 | 11 |
| 2023 | 11 | 0 | 11 |
| 2024 | 9 | 0 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chagas Disease" by people in Profiles.
-
Immunopeptidomic MHC-I profiling and immunogenicity testing identifies Tcj2 as a new Chagas disease mRNA vaccine candidate. PLoS Pathog. 2024 Dec; 20(12):e1012764.
-
Chagas disease in the immunocompromised host. Curr Opin Infect Dis. 2024 Oct 01; 37(5):333-341.
-
Chronic Chagas Disease in the US. JAMA. 2024 06 18; 331(23):2037-2038.
-
Trypanosoma cruzi Infection in Pregnancies without Congenital Transmission Is Associated with Reduced Fetal Growth: A Cross-Sectional Study in Argentina, Honduras, and Mexico. Am J Trop Med Hyg. 2024 Jul 03; 111(1):64-72.
-
Chagas disease in immunocompromised patients. Clin Microbiol Rev. 2024 Jun 13; 37(2):e0009923.
-
Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease. ACS Appl Mater Interfaces. 2024 Apr 03; 16(13):15832-15846.
-
Adaptation of Chagas Disease Screening Recommendations for a Community of At-risk HIV in the United States. Clin Infect Dis. 2024 02 17; 78(2):453-456.
-
Novel species of Triatoma (Hemiptera: Reduviidae) identified in a case of vectorial transmission of Chagas disease in northern Belize. Sci Rep. 2024 01 16; 14(1):1412.
-
Chagas Disease Diagnostic Practices at Four Major Hospital Systems in California and Texas. J Infect Dis. 2024 01 12; 229(1):198-202.
-
The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection. PLoS Negl Trop Dis. 2023 Nov; 17(11):e0011519.